General Information:

Id: 3,540 (click here to show other Interactions for entry)
Diseases: Alzheimer disease - [OMIM]
Homo sapiens
Reference: Weggen S et al.(2003) Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain J. Biol. Chem. 278 [PMID: 12777371]

Interaction Information:

Comment Abeta42-lowering NSAIDs (Non-steroid antiinflammatory drugs) do not impair AICD or ErbB4 C-terminal fragment generation.
Formal Description
Interaction-ID: 32992

drug/chemical compound


decreases_quantity of